Recently sold LoHi building leases up, DTC apartments fetch nearly $65 million and a 73,000-square-foot industrial lease is ...

NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the progress ...

Vanda advances with strong Fanapt growth, late-stage catalysts, GLP-1 potential, higher investment and solid balance sheet support. Read why VNDA stock is a buy.

This article first appeared on GuruFocus. If you are going to make your first investment in a bio-tech company, might as well do it in a strong one like Vertex Pharmaceuticals (NASDAQ:VRTX). Shares ...

Arcutis Biotherapeutics is rated a buy with a $19 price target, driven by strong Zoryve sales, a solid balance sheet, and strategic CFO transition. CFO David Topper is stepping down, replaced by Latha ...

America’s technology frontier is expanding rapidly, fueled by artificial intelligence and ...